FDA Inspection 1087290 — Synovis Life Technologies, Inc. (sub. of Baxter Int'l, Inc.)

Synovis Life Technologies, Inc. (sub. of Baxter Int'l, Inc.) — FEI 2183620

The FDA completed an inspection of Synovis Life Technologies, Inc. (sub. of Baxter Int'l, Inc.) on April 24, 2019 in Saint Paul, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 24, 2019
Fiscal Year
2019
Product Type
Devices
Project Area
Compliance: Devices
Location
Saint Paul, MN (United States)

Citations

IDCFRDescription
313021 CFR 820.100(a)Lack of or inadequate procedures
368021 CFR 820.70(a)Process control procedures, Lack of or inadequate procedures